From: Paediatric massage for treatment of acute diarrhoea in children: a meta-analysis
Study | Sample size | Age | Course of disease | Intervention group | General classification of the massage therapy | Control group |
---|---|---|---|---|---|---|
Cheng (2014) | 72 (36/36) | 1.9 ± 0.5 y | 3.6 ± 1.1 d | massage 3 d | BMT + PSAP | (1) montmorillonite (2) combined bacillus subtilis and enterococcus faecium 3 d |
Du (2009) | 100 (52/48) | 19 ± 5 m | 1.2 ± 0.5 d | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Gao (2005) | 60 (30/30) | 18 ± 6 m 17 ± 6.5 m | 1.3 ± 0.5 d 1.2 ± 0.6 d | massage 3 d | BMT + PSAP | (1) montmorillonite (2) combined bacillus subtilis and enterococcus faecium 3 d |
Leng (2011) | 26 (20/6) | 3 m to 5 y | ≤1w | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Li K (2013) | 61 (30/31) | <  3 y | <  2 w | massage 3 d | BMT + PSAP | (1) Cangling antidiarrhea oral solution (2) montmorillonite (3) bifidobacterium 3 d |
Li X (2015) | 176 (87/89) | 2 m to 3 y 1.5 m to 2 y and 11 m | <  2 w | massage 5 d | IMT | montmorillonite 5 d |
Ma (2016) | 80 (40/40) | 3 m to 4 y | <  1 w | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Ni (2018) | 70 (35/35) | 1.67 ± 1.41 y 1.64 ± 1.39 y | 3.16 ± 0.82 d 3.19 ± 0.87 d | massage 7 d | BMT + PSAP | norfloxacin 7d |
Peng (2011) | 240 (180/60) | 3 m to 5 y | 2.81 ± 1.61 d 2.78 ± 1.39 d | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Shao (2006) | 120 (68/52) | 18 ± 6 m 17 ± 6 m | 1.3 ± 0.5 d 1.2 ± 0.6 d | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Tang (2014) | 135 (67/68) | 1.84 ± 0.33 y 1.87 ± 0.37 y | 6.84 ± 2.21 d 6.58 ± 2.13 d | massage | BMT + PSAP | montmorillonite |
Tao (2015) | 60 (30/30) | 2.03 ± 1.21 y 2.30 ± 1.16 y | 2.81 ± 1.31 d 2.70 ± 1.20 d | massage 3 d | BMT + PSAP | (1) montmorillonite (2) clostridium butyricum 3 d |
Wang (2004) | 88 (48/40) | 6 m to 3 y | all were acute diarrhea | massage 3 d | BMT + PSAP | (1) intravenous drip ribavirin (2) montmorillonite (3) lactobacillus 3 d |
Wang (2014) | 86 (43/43) | 1.75 ± 0.37 y 1.25 ± 0.14 y | 3.47 ± 0.34 d 3.41 ± 0.24 d | massage 3 d | BMT + PSAP | (1) norfloxacin (2) ciprofloxacin 5 d |
Yang (2016) | 80 (40/40) | 1.60 ± 0.72 y 1.81 ± 0.68 y | <  1 w | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Yang (2013) | 69 (36/33) | 6 m to 3 y 6 m to 3.5 y | 1–5 d 1–6 d | massage 6 d | BMT + PSAP | (1) montmorillonite (2) combined bacillus subtilis and enterococcus faecium (3) bifidobacterium 6 d |
Yin (2000) | 50 (30/20) | <  3 y | <  3 d | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Yin (2009) | 315 (190/125) | 2 m to 5 y | <  48 h | massage 3 d | IMT | montmorillonite 3 d |
You (2013) | 55 (32/23) | 11.55 ± 4.68 m 10.58 ± 5.05 m | 3.25 ± 1.06 d 3.39 ± 1.15 d | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Zhang (2016) | 180 (90/90) | 2.41 ± 1.6 y 2.5 ± 1.2 y | 2.8 ± 1.4 d 2.9 ± 1.2 d | massage 6 d | BMT + PSAP | (1) montmorillonite (2) bifidobacterium 6 d |
Zhang (2011) | 64 (32/32) | <  3 y | 1 to 3 d | massage 3 d | BMT + PSAP | (1) probiotics (2) mucosal protection 3 d |
Zhao (2016) | 80 (40/40) | 3.1 ± 0.6 y 3.3 ± 0.7 y | 14.2 ± 2.1 h 13.2 ± 1.7 h | massage 3 d | BMT + PSAP | (1) enterococcus faecium (2) bifidobacterium (3) montmorillonite 3 d |
Zhu (2004) | 90 (60/30) | <  3 y | ≤3 d | massage 3 d | BMT + PSAP | montmorillonite 3 d |
Li G (2013) | 120 (60/60) | 1.5 ± 0.3 y | <  3 d | massage + acupuncture 3 d | IMT + Acupuncture | montmorillonite 3 d |
Wang (2003) | 99 (52/47) | 1.7 ± 1.1 y 1.8 ± 1.2 y | <  3 d | massage + acupuncture 3 d | BMT + IMT + Acupuncture | montmorillonite 3 d |
Wei (2016) | 68 (34/34) | 12.6 ± 5.7 m 11.9 ± 5.3 m | 3.1 ± 0.3 d 3.2 ± 0.4 d | massage + acupuncture 7 d | BMT + IMT + Acupuncture | combined bacillus subtilis and enterococcus faecium 7 d |